Gonorrhea and chlamydia in the United States among persons 14 to 39 years of age, 1999 to 2002
- PMID: 17638719
- DOI: 10.7326/0003-4819-147-2-200707170-00007
Gonorrhea and chlamydia in the United States among persons 14 to 39 years of age, 1999 to 2002
Abstract
Background: Nationally representative surveys of chlamydia and gonorrhea are an important measure of disease burden and progress of screening programs.
Objective: To measure chlamydia and gonorrhea prevalence in the United States.
Design: Analysis of sexual history information and urine specimens collected in the National Health and Nutrition Examination Survey (NHANES), 1999-2002.
Setting: U.S. civilian noninstitutionalized population as sampled by NHANES, 1999-2002.
Participants: 6632 NHANES respondents.
Measurements: Urine specimens were tested for chlamydia and gonorrhea. Results were weighted to represent the U.S. civilian, noninstitutionalized population between 14 and 39 years of age.
Results: Prevalence of gonorrheal infection was 0.24% (95% CI, 0.16% to 0.38%). Prevalence of gonorrheal infection was higher among non-Hispanic black persons (1.2% [CI, 0.7% to 1.9%]) than among non-Hispanic white persons (0.07% [CI, 0.02% to 0.24%]). Among those with gonorrheal infection, 46% also had chlamydial infection. Prevalence of chlamydial infection was 2.2% (CI, 1.8% to 2.8%) and was similar between males (2.0% [CI, 1.6% to 2.5%]) and females (2.5% [CI, 1.8% to 3.4%]). Among females, the highest prevalence was in those age 14 to 19 years, whereas among males, it was highest in those age 14 to 29 years. Prevalence was higher among non-Hispanic black persons (6.4% [CI, 5.4% to 7.5%]) than non-Hispanic white persons (1.5% [CI, 1.0% to 2.4%]). Among females with a history of gonorrhea or chlamydia in the previous 12 months, chlamydia prevalence was 16.7% (CI, 5.5% to 50.7%).
Limitations: The specificity of urine-based assays for chlamydia and gonorrhea is limited, and the possible misclassification of sexual experience status may have affected the accuracy of some estimates.
Conclusions: The findings support current recommendations to screen sexually active females age 25 years or younger for chlamydia, to retest infected females for chlamydial infection, and to co-treat individuals with gonorrhea for chlamydia.
Summary for patients in
-
Summaries for patients. Gonorrhea and chlamydia in the United States among persons 14 to 39 years of age.Ann Intern Med. 2007 Jul 17;147(2):I22. doi: 10.7326/0003-4819-147-2-200707170-00002. Ann Intern Med. 2007. PMID: 17638717 No abstract available.
Similar articles
-
Prevalence of Chlamydia trachomatis genital infection among persons aged 14-39 years--United States, 2007-2012.MMWR Morb Mortal Wkly Rep. 2014 Sep 26;63(38):834-8. MMWR Morb Mortal Wkly Rep. 2014. PMID: 25254560 Free PMC article.
-
Prevalence of chlamydial and gonococcal infections among young adults in the United States.JAMA. 2004 May 12;291(18):2229-36. doi: 10.1001/jama.291.18.2229. JAMA. 2004. PMID: 15138245
-
Trends in chlamydia prevalence in the United States, 2005-2016.Sci Rep. 2024 May 23;14(1):11825. doi: 10.1038/s41598-024-61818-5. Sci Rep. 2024. PMID: 38783017 Free PMC article.
-
Screening Recommendations for Chlamydia and Gonorrhea.JAMA Dermatol. 2015 Sep;151(9):1014-6. doi: 10.1001/jamadermatol.2015.1987. JAMA Dermatol. 2015. PMID: 26177006 Review.
-
Screening for sexually transmitted diseases in short-term correctional institutions: summary of evidence reviewed for the 2010 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.Sex Transm Dis. 2013 Sep;40(9):679-84. doi: 10.1097/01.olq.0000431353.88464.ab. Sex Transm Dis. 2013. PMID: 23945422 Review.
Cited by
-
Chlamydia trachomatis Infection: Screening and Management.J Clin Outcomes Manag. 2014 Jan;21(1):30-38. J Clin Outcomes Manag. 2014. PMID: 25554725 Free PMC article.
-
Perceived Stress and Molecular Bacterial Vaginosis in the National Institutes of Health Longitudinal Study of Vaginal Flora.Am J Epidemiol. 2021 Nov 2;190(11):2374-2383. doi: 10.1093/aje/kwab147. Am J Epidemiol. 2021. PMID: 34008013 Free PMC article.
-
Immunogenicity of a vaccine formulated with the Chlamydia trachomatis serovar F, native major outer membrane protein in a nonhuman primate model.Vaccine. 2011 Apr 18;29(18):3456-64. doi: 10.1016/j.vaccine.2011.02.057. Epub 2011 Mar 4. Vaccine. 2011. PMID: 21376796 Free PMC article.
-
Neisseria gonorrhoeae and Chlamydia trachomatis among human immunodeficiency virus-infected women.Sex Transm Dis. 2008 Oct;35(10):859-61. doi: 10.1097/OLQ.0b013e31817bbcb4. Sex Transm Dis. 2008. PMID: 18641536 Free PMC article. No abstract available.
-
Chlamydia prevalence in the general population: is there a sex difference? a systematic review.BMC Infect Dis. 2013 Nov 11;13:534. doi: 10.1186/1471-2334-13-534. BMC Infect Dis. 2013. PMID: 24215287 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical